article thumbnail

Top Legal Concerns for Manufacturers

L4SB

Navigating the legal landscape is a challenge for manufacturers, as their operations are subject to an array of complex and evolving regulations. Understanding these legal concerns and addressing them proactively.

article thumbnail

FDA Grants A Registration Fee Waiver for Very Small, Broke Device Manufacturers

FDA Law Blog

Gibbs — Our last post on small business certification requests described how small medical device manufacturers, defined as those with gross receipts of less than $100 million in gross receipts and sales for the most recent tax year, are eligible for a reduced fee on those medical device submissions that require a user fee.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Discounts Available! Submit a Small Business Certification Request Today for a Reduced Medical Device User Fee

FDA Law Blog

By Véronique Li, Senior Medical Device Regulation Expert & Philip Won — In our last blog post , we advised medical device companies to consider applying to FDA’s Small Business Program to help with the noticeably higher user fees for FY2023. In this blog post, we provide a primer on user fees and the Small Business Program.

article thumbnail

A New Era in Cosmetics Regulation: The Modernization of Cosmetic Regulations Act

Customs & International Trade Law

Recent news on the Voluntary Cosmetic Regulations Program (VRCP) The VCRP was a voluntary program that allowed manufacturers, packers, and distributors of cosmetic products to submit product information to the FDA. Existing facilities have until December 29, 2023 to register.

article thumbnail

South Africa: Managed Cyber Security Risk Prevention Program - SNG Grant Thornton

Mondaq

Cybercrime is a global phenomenon that does not discriminate on the size of your organisation, whether you are in finance, manufacturing, national government, small business, or entrepreneur.

article thumbnail

Canada dispatch: Ambassador Bridge blockade cleared, but Ottawa occupation continues

JURIST

The blockade created significant supply chain issues on both sides of the border leading to concerns from the White House, temporary manufacturing plant closures in Canada, and renewed calls from some US politicians for more domestic—or made in America—production.

article thumbnail

DEA Updates Special Surveillance List of Precursor Chemicals and Equipment

FDA Law Blog

Houck — The Drug Enforcement Administration (“DEA”) has issued its notice finalizing updates to its longstanding Special Surveillance List of chemicals and equipment used in the illicit manufacture of controlled substances and listed chemicals. 73,044 (Oct. DEA’s notice of updates with the Special Surveillance List is attached here.